1 completed, 1 unknown. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow GC3107: new trials by email Literature Review of GC3107 trials Research Report on GC3107
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of GC3107(BCG Vaccine) in Healthy Infants GC3107, Intradermal BCG SSI inj. - BCG Vaccination Reaction, Tuberculosis | Phase 3 | Completed | Green Cross Corporation | 750 | 2019-08-06 | 2022-11-02 |
| Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults GC3107 - Tuberculosis | Phase 1 | Unknown | Green Cross Corporation | 20 | 2017-12-14 | 2017-12-18 |
Tuberculosis (2)
South Korea (2)
JongHyun Kim, MD (1) · Woo Joo Kim, M.D, Ph.D (1)